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Abstract
Objectives: To evaluate the long term neurodevelopmental outcome of premature infants exposed to either gram-
negative sepsis (GNS) or neonatal Candida sepsis (NCS), and to compare their outcome with premature infants without
sepsis.
Methods: Historical cohort study in a population of infants born at ,30 weeks gestation and admitted to the Neonatal
Intensive Care Unit (NICU) of the Academic Medical Center in Amsterdam during the period 1997–2007. Outcome of infants
exposed to GNS or NCS and 120 randomly chosen uncomplicated controls (UC) from the same NICU were compared.
Clinical data during hospitalization and neurodevelopmental outcome data (clinical neurological status; Bayley –test results
and vision/hearing test results) at the corrected age of 24 months were collected. An association model with sepsis as the
central determinant of either good or adverse outcome (death or severe developmental delay) was made, corrected for
confounders using multiple logistic regression analysis.
Results: Of 1362 patients, 55 suffered from GNS and 29 suffered from NCS; cumulative incidence 4.2% and 2.2%,
respectively. During the follow-up period the mortality rate was 34% for both GNS and NCS and 5% for UC. The adjusted
Odds Ratio (OR) [95% CI] for adverse outcome in the GNS group compared to the NCS group was 1.4 [0.4–4.9]. The adjusted
ORs [95% CI] for adverse outcome in the GNS and NCS groups compared to the UC group were 4.8 [1.5–15.9] and 3.2 [0.7–
14.7], respectively.
Conclusions: We found no statistically significant difference in outcome at the corrected age of 24 months between
neonatal GNS and NCS cases. Suffering from either gram –negative or Candida sepsis increased the odds for adverse
outcome compared with an uncomplicated neonatal period.
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Introduction
Nosocomial infections caused by gram negative and Candida
sepsis in the Neonatal Intensive Care Unit (NICU) may lead to
overt clinical sepsis increasing the risk for mortality, co- morbidity
and long-term neurodevelopmental sequelae [1–3]. Extremely
Low Birth Weight (ELBW) and Very Low Birth Weight (VLBW)
infants are the most fragile and immunologically compromised
patients in the NICU [2,4,5]. Well known risk factors for
nosocomial sepsis in this population are surgery (mostly for
Necrotising Entero Colitis, NEC), prolonged ventilatory support,
the use of total parenteral nutrition (TPN), indwelling central
venous catheters (CVC), corticosteroid medication use and the
frequent use of broad-spectrum antibiotics [2,6–10].
Sepsis episodes caused by gram- negative bacteria (gram-
negative sepsis; GNS) and neonatal Candida sepsis (NCS) are both
associated with high mortality and morbidity rates, ranging from
19–36% and 32–44% respectively [1,2,9–11]. The reported
cumulative incidence of GNS in the NICU varies from 2.7 to
4.4% [3,12,13], compared with 1.7 to 9.0% [3,6,10,12] for NCS.
In GNS Escherichia coli and Klebsiella pneumoniae are the most
frequently encountered microorganisms [7,14,15]. Most common-
ly reported causative microorganisms in NCS are Candida albicans
and Candida parapsilosis [6,16].
Long- term neurological sequelae of GNS and NCS in VLBW
infants have been reported in 45% and 57% of exposed infants
respectively [3]. The presence of meningitis during neonatal sepsis
is a major additional risk factor for adverse outcome [4,17].
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Reports on the long-term outcome of infants suffering
nosocomial sepsis are sparse. The aim of this study was therefore
to investigate the odds for adverse outcome (death or severe
neurodevelopmental delay) in infants with a gestational age ,30
weeks admitted at a tertiary NICU suffering either GNS or NCS
in comparison with the outcome of infants without sepsis.
Methods
Research Design and Population
Data from a historical cohort were used. The basic population
consisted of all infants born at a gestational age ,30 weeks
admitted to the NICU of the Academic Medical Center (AMC),
Amsterdam, The Netherlands between January 1st 1997 and
December 31st 2007.
All neonates from this population with a bacteriological di-
agnosis of either gram-negative sepsis (GNS) or neonatal Candida
sepsis (NCS) (only positive peripheral blood cultures) were
included to compare the long- term outcome of these cases.
In order to compare the long- term outcome of GNS and NCS
with the outcome of uncomplicated neonatal infants (no sepsis but
undergoing identical NICU care) admitted at the same NICU
during the same time period and undergoing the same routine
care, we randomly selected a set of neonates, without any type of
sepsis, from the remaining cases of the same population (UC
group). For each case of GNS or NCS, at least 2 control subjects
were randomly selected by choosing every other 5th subject from
the same basic population. From February to December 2011
clinical and microbiological data were obtained retrospectively
from existing written and partly digital medical files, the digital
records of the Patient Data Management System (PDMS), the
digital clinical chemistry and medical microbiological laboratory
databases and the digital long- term follow–up database of the
NICU (FUN database).
As existing clinical data were used, collected during the clinical
course of these patients and as analyses and reporting of these data
was performed anonymously, the approval of the institutional
medical ethical committee or signed parental consent were not
needed for this research according to Good Clinical Practice - and
local legislation, including the Data Protection Act (Wet
Bescherming Persoonsgegevens; WBP) and the Medical Contract
Bill (Wet Geneeskundige Behandelings-overeenkomst); WGBO.
Study Population
Inclusion and exclusion criteria. Patients were included in
the GNS or NCS group only when when either gram-negative
bacteria or Candida species were found in peripheral blood
cultures and if patients were defined as having a clinical sepsis (see
below). Only the microorganisms found in the blood cultures were
deemed as the causative organism for the sepsis episode.
Patients were not included in these study-groups if only positive
central line cultures were found for either yeast or gram negative
bacteria as central line culture results may be misleading.
Clinical sepsis was defined as having at least two of the following
symptoms: 1) any increase in frequency or duration of apnoea or
bradycardia episodes (not related to feeding problems or airway
obstruction) necessitating an increase in ventilatory support
(intubation and ventilation; Nasal Intermittent Positive Pressure
Ventilation; or increase in Continuous Positive Airway Pressure );
2) hypothermia (core body temperature of ,36.5uC) or hyper-
thermia (core body temperature of .38.5uC); 3) circulatory
compromise: a systolic blood pressure ,P5 according to gesta-
tional age corrected values.
Patients were included as uncomplicated control group (UC
group) subjects if 1) during hospital stay no clinical or bacterio-
logical signs of infection (sterile blood cultures on admission) were
identified; 2) either ventilatory support by infant flow CPAP or
short (,72 hrs.) ventilation for infant respiratory distress (IRDS)
was given and 3) they had received routine NICU care (including
indwelling catheters and parenteral nutrition). All infants with
possible syndromal traits were excluded.
Measures
Long-term neurodevelopment and outcome
measures. Outcome was defined as adverse in infants who
either 1) died or 2) suffered cerebral palsy either alone or in
combination with clinical hearing loss or visual handicaps (mostly
ROP) or 3) had MDI/PDI BSID-II-NL results ,85.
Post discharge mortality was investigated by evaluating
discharge letters and obtaining information from treating physi-
cians in all patients for the follow-up period of the study (24
months corrected age). For all infants the neurodevelopmental
outcome was assessed at the corrected age of 24 months by
a trained neuropsychologist using the Bayley Scales of Infant
Development (Second Edition-Dutch version: BSID-II-NL)
[18,19]. This comprises three separate scales (mental scale, motor
scale and behavioral rating). Mental and motor scale scores are
converted to a mental developmental index (MDI) and a psycho-
motor developmental index (PDI) with a mean of 100 and
a standard deviation (SD) of 15. Normal limits are defined as MDI
and PDI values between 85 and 114. Values of 70–84 are defined
as mildly delayed. A score of ,70 is defined as severely delayed
[20]. The BSID-II has been shown to be reproducible and valid
[18,19]. All infants also underwent a standardised neurological
examination performed by trained paediatricians. Some neonatol-
ogists of the NICU participate in the long term neonatal follow up
program of our hospital. Also digital medical data were available
for review for the neuropsychologists and paediatricians perform-
ing the outcome assessments. Therefore (and because of the
retrospective nature of this study) neurodevelopmental assessment
was not blinded for the clinical history.
Outcome was defined as good in survivors with a normal
neurological examination, no evidence of hearing loss or visual
impairment and Mental Developmental Index (MDI)/Psychomo-
tor Developmental Index (PDI) BSID –II-NL score .85. Hearing
investigation (newborn hearing screening: digital data) and
specialist ophthalmic investigation results (screening for ROP)
were digitally available for all cases.
Clinical Information
Information was retrieved from the medical files on: the time (in
days) to the onset of sepsis (counted from the date of admission);
total duration of hospitalization (in days), birth weight (grams),
gestational age (weeks), Apgar scores, total duration of ventilatory
(either intubation and ventilation or CPAP) or inotropic support,
total duration of parenteral nutrition and indwelling CVC (all in
days). The need for invasive surgical procedures was recorded as
well as use of corticosteroid medication.
The following variables were recorded in a dichotome manner:
1) presence of bacterial meningitis; 2) abnormal cerebral
ultrasound result (defined as any abnormality detected); 3)
presence of retinopathy of prematurity (ROP) [21,22]; 4) the
presence of bronchopulmonary dysplasia (BPD) (defined as the
need for supplemental oxygen at 36 weeks postmenstrual age)
[23,24]; 5) abnormal newborn hearing (ALGO) screening result.
To evaluate disease severity at the start of sepsis the Neonatal
Therapeutic Intervention Scoring System (NTISS, range 0 to 130)
Neonatal Gram-Negative and Candida Sepsis
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was recorded as a continuous variable. This instrument assesses
severity of illness by quantifying the intensity and complexity of
care received by a patient. It is based on the assumption that
therapeutic intensity is a direct correlate of illness severity, given
similar philosophies or styles of care. [25]. The systematic use of
the NTISS score was implemented in our unit in 1999.
Microbiology Data
Microbiological information was recorded on the basis of the
blood culture results only. According to the clinical protocol all
peripheral blood cultures had been taken prior to start of any
antimicrobial therapy. The diagnosis of meningitis was considered
as proven only when CSF cultures were positive. Blood cultures
were incubated in a semi-automatic system, the BacT/Alert
(bioMerieux, Boxtel, the Netherlands). For a blood culture
a minimum of 2.0 ml of blood was taken and divided over two
bottles (FAN-aerobic: 1.0 ml & FAN-anaerobic: 1.0 ml). Suscep-
tibility to antibacterial and antimycotic agents was determined on
Isosensitest and RPMI-plates respectively using disk diffusion
(Rosco, Taastrup, Denmark) or on MH plates with E-test
(bioMerieux) according to the manufacturers’ instructions. Mul-
tiple positive cultures with the same causative microorganism
within 7 days were interpreted as one identical sepsis episode.
Multiple sepsis episodes were defined as consecutive episodes of
clinical sepsis with positive blood cultures with a disease free
interval of at least 7 days.
Statistical Analysis
Statistical analysis was performed with SPSS 18.0 statistical
software package (SPSS Inc., Chicago, IL). Independent samples t-
tests were used to compare sample means of continuous clinical
variables between the GNS and the NCS cohort and between each
cohort and the control group. Skewed data were log- transformed.
The Mann-Whitney-U test was performed if data were not
distributed normally and log transformation did not result in
a normal distribution. The Chi squared-test was used for the
analysis of nominal data. Differences were considered statistically
significant when 2-tailed p-values were ,0.05.
To analyse the association between the central determinant
‘‘sepsis exposure’’ (GNS, NCS or UC) and outcome (defined as
either ‘‘adverse’’ or ‘‘good’’) multiple logistic regression analysis
was performed. Two association models were produced, one crude
model unadjusted for confounding and a model adjusted for
confounders.
Adjusted estimates for cohort type as a risk factor for adverse
outcome were obtained by entering potential confounders in the
model one by one. The presence of confounding, defined as
a change in the regression coefficient of the central determinant
(i.e. cohort type) of .10%, and effect modification, defined as
a statistically significant effect of an interaction term, was
investigated for all potential confounders in the model in a pre-
defined order. Potential confounders were: gestational age; birth
weight; total duration of hospitalization (in days); duration of
central venous catherization and parenteral nutrition (days);
duration of inotropic and ventilatory support (in days); duration
of CPAP support (in days); ALGO and ROP screening results;
BPD diagnosis at 36 weeks PMA; multiple episodes of infection;
neonatal NTISS score and ultrasound result. The presence of co-
linearity was investigated by simultaneously adding two co-
variables to the regression model that were suspected to cause
co-linearity based on a high mutual correlation (e.g. duration of
ventilatory and CPAP support). Either a large change in the
standard error or a change of the direction of the regression
coefficient of these co variables compared with a model containing
only one of the 2 co -variables was interpreted as co-linearity.
Results
Candida Sepsis, Gram-negative Sepsis and Control
Subjects
During the period of 1997–2007, 1362 patients with a gesta-
tional age ,30 weeks were admitted at the NICU of the AMC. In
the study period 57 patients had a positive peripheral blood
culture for gram-negative bacteria. Two patients were excluded
from this group because there were no clinical signs of sepsis and
no positive blood cultures were noted (only a positive central line
culture), leaving a group of 55 cases (cumulative incidence 4%). In
the same study period there were 31 patients with a peripheral
positive blood culture for yeast sepsis; 2 patients were excluded
from this group because there were no clinical signs of sepsis and
no positive blood cultures were noted (only a positive central line
culture), leaving a group of 29 cases (cumulative incidence 2%).
There were no patients in our study with only a positive central-
line culture and signs of sepsis.
The control group consisted of 120 infants with an un-
complicated clinical course as defined above. The population
flow chart is demonstrated in figure 1. Table 1 demonstrates the
characteristics of the GNS, NCS and UC groups. Infants who
developed GNS and NCS had significantly smaller birth weights
than the UC (p,0.001.
Main Study Outcome: Adverse Long-term
Neurodevelopment or Demise
Mortality was highly comparable between the GNS and NCS
groups (19/55 and 10/29 respectively). All deaths occurred during
admission at the NICU.
As Figure 1 demonstrates, the loss to follow–up at the corrected
age of 24 months was limited (8%). Table 2 demonstrates the
neurodevelopmental outcome results in detail.
At follow –up of the NCS group normal vision was noted in
82% and normal hearing was observed in 76%. The outcome of
the clinical neurological exam was normal in 41% of the patients.
In the GNS group normal vision was noted in 70% and in 82%
there was no hearing impairment. The outcome of the clinical
neurological examination was normal in 55% of the patients.
In the uncomplicated control group (UC) 92% had no vision
impairment and 99% had no hearing impairment. The outcome
of the clinical neurological examination was normal in 85%.
Combining these findings with the available BSID test results
and the mortality results, adverse outcome was noted in 48% of
the NCS; 56% of the GNS group and 16% of the UC group.
The statistical analyses demonstrated no statistically significant
difference in the odds for adverse outcome (either death or severe
neurodevelopmental delay) between the GNS and NCS infants or
between the NCS group and the UC group but the OR [95% CI]
for adverse outcome in the GNS group compared to the UC group
was 4.8 [1.5–15.9]. The crude and adjusted odds ratios (OR)
estimated in the regression models are demonstrated in table 3.
Effect modification was not found. Co-linearity was found for the
duration of indwelling CVC and total duration of parenteral
nutrition and for duration of intubation and ventilation and CPAP
support. The dichotomous covariable of meningitis and the
ordinal covariable ‘‘maternal education type’’ could not be
entered in the model as unfortunately .50% of data was missing
for both. The events of either surgery for NEC or suffering
multiple sepsis episodes did not influence our findings concerning
the odds for adverse outcome.
Neonatal Gram-Negative and Candida Sepsis
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The Clinical Course
Clinical parameters are also shown in table 1. There were no
statistically significant differences in any of the clinical parameters
between GNS and NCS cases. For gram-negative sepsis Klebsiella
pneumoniae, E. coli and Enterobacter cloacae were the most common
causative pathogens. The most common causative species for
Candida sepsis were C. albicans and C. parapsilosis. Multiple sepsis
episodes occurred in both sepsis groups. In the yeast sepsis group
45% of the patients had experienced multiple episodes of sepsis,
compared to 20% of the patients in the gram-negative sepsis
group. Table 4 demonstrates the species found in the blood-
cultures during these multiple sepsis episodes. During the study
period, antimycotic prohylaxis was not prescribed.
Retinopathy and Bronchopulmonary Dysplasia
The cumulative incidences of ROP and BPD are shown in
table 1. In the GNS group ROP screening results were available
for all patients (n = 55). Abnormal results were found in 13 infants
(24%) (stage 1: n= 5; stage 2: n = 3; stage 3: n= 5). BPD was
diagnosed in 9/55 infants (16%).
In the Candida sepsis group ROP screening results were
available for 27/29 infants (93%). Abnormal results were found in
8 infants (30%) (stage 1: n= 3; stage 2: n= 2; stage 3: n= 3). BPD
was diagnosed in 7/29 infants (24%).
In the uncomplicated controls ROP screening results were
available for all 120 infants. Abnormal results were found in 12
infants (10%) (stage 1: n= 10; stage 2: n= 1; stage3: n = 1). Two
infants were diagnosed with BPD (2%).
Discussion
Our data did not demonstrate any statistically significant
difference in the odds for adverse outcome between GNS and
NCS cases. In a comparable report by Stoll et al. evaluating
outcome of neonatal sepsis in ELBW infants at the corrected ages
of 18 and 22 months no significant difference was found between
NCS and GNS cases either [3]. Outcome was however not
compared to neonatal controls without sepsis in their report. In
our study the OR for adverse outcome comparing the GNS and
NCS group with UC was high, emphasizing the devastating effect
of sepsis on long-term outcome and mortality. It is important to
compare our study population to those of previous reports. The
incidence of GNS of 4% in our population was comparable to
previously reported incidences of 2.7–4.4% [9,26]. The incidence
of NCS in our population was 2%, which is also in accordance
with reported incidence of 1.9–9.0% [1,8,10]. The mortality rate
of 34% for both the GNS and NCS cases was comparable to the
mortality ranges as reported previously (19–36%, and 32–44%
Figure 1. Population Flow sheet. LFUP: Long Term Follow Up completed; LTF: Loss to follow up.
doi:10.1371/journal.pone.0059214.g001
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respectively) [2,9–11]. In line with previous findings, infants
Table 1. Population Characteristics.
Characteristics NCS n=29 GNS n=55 UC n=120
Mean SD Mean SD Mean SD
Birth Weight (grams) 936.6 208.2 933.3 197.8 1130.9 277.6
Gestational Age (weeks) 27.1 1.4 27.0 1.5 28.6 1.2
Apgar score at 10 min 8 2.1 7.9 1.3 8.6 1.1
n % n % n %
Male gender 15 52 34 62 58 48
Clinical Characteristics Median IQR Median IQR Median IQR
Days from admission until sepsis episode 16 11–24 17 9–29 n.a n.a.
Total days of mechanical ventilation 14 6–20 8 3–14 0 0–0
Total days of CPAP 14 6–34.5 26 13–37 5 1–14
Total days of inotropic use 5 0–12.5 1 0–6 n.a. n.a.
Total days of TPN use 24 13.5–40 20 14–30 8 5–11
Total days of indwelling CVL 27.5 19.25–46.5 24 12–34 7 4.25–10.75
Total days of hospital stay 43 29.5–99.5 50 26.25–69.25 21.5 10–35.75
Mean SD Mean SD
NTISS 21.7 6.5 23.4 10.2 n.a n.a
n/N % n/N % n/N %
Postnatal steroids 5/29 17 4/55 7 0/120 0
NEC 6/29 21 10/55 18 1/120 1
CUS normal 13/29 45 34/54c 63 91/117c 78
CUS abnormal 16/29 55 20/54c 37 26/117c 22
BPD36 7/29 24 9/55 16 2/120 2
ROP 8/27c 30 13/55 24 12/120 10
Good outcome (normal/mild delay) 14/27c 52% 23/52c 44% 92/109c 84%
Adverse outcome (death*/severe
delay)
13/27c 48% 29/52c 56% 17/109c 16
cNumber of subjects for whom the information was obtained. NCS: Neonatal candida Sepsis; GNS: Gram Negative Sepsis; UC: Uncomplicated Controls; Abbrevations:
NEC: surgery for Necrotising Entero Colitis; n.a. = not applicable; IQR = Interquartile Range; SD= standard deviation, BPD36 = diagnosis BPD at 36 weeks, ROP:
Retinopathy of Prematurity; NTISS: Neonatal Therapeutic Intervention Score; CUS: cerebral ultrasound; CVL: central venous line; Good outcome= as defined in methods;
Adverse outcome= as defined in methods.
*death: all deaths were during admission, no postdischarge mortality.
doi:10.1371/journal.pone.0059214.t001




Follow up n: 17
GNS
n=55
Follow up n: 33
UC
n=120
Follow up n: 102
Bayley PDI * 76 (59–100) 84 (52- 110) 91 (54- 135)
Bayley MDI* 92 (78- 108) 90 (54- 128) 100 (54- 131)
Neurology exam#
Normal 7/17 (41%) 18/33 (55%) 87/102 (85%)
Mildly abnormal 9/17 (53%) 8/33 (24%) 13/102 (13%)
Severely abnormal 1/17 (6%) 7/33 (21%) 2/102 (2%)
Hearing
disabilities
4/17 (24%) 6/33 (18%) 1/102 (1%)
Visual handicaps 3/17 (18%) 10/33 (30%) 8/102 (8%)
NCS: Neonatal Candida Sepsis; Gram Negative Sepsis; UC: Uncomplicated
Controls. FU: Follow Up.
*Median, minimum-maximum. #: number of total cases noted and percentage.
PDI: Psychomotor Developmental Index; MDI: Mental Developmental Index.
doi:10.1371/journal.pone.0059214.t002
Table 3. Raw and adjusted association (Odds Ratios)
between sepsis type and adverse outcome.
Cohort type Crude OR CI
GNS versus NCS 1.4 0.5–3.5
GNS versus UC 6.8 3.2–14.5
NCS versus UC 5.0 2.0–12.5
Adjusted OR CI
GNS versus NCS 1.4 0.4–4.9
GNS versus UC 4.8 1.5–15.9
NCS versus UC 3.2 0.7–14.7
GNS: gram negative sepsis; NCS: neonatal Candida sepsis; UC: uncomplicated
control infants; OR: odds ratio; CI: 95% confidence interval; Adjusted for the
following confounders: gestational age; abnormal newborn hearing test;
duration of ventilation; total number of days admitted.
doi:10.1371/journal.pone.0059214.t003
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suffering clinical sepsis were generally smaller in birth weight than
infants with an uncomplicated course [1–3,27].
The distribution of both the Candida species and the gram-
negative species in our study population is comparable to previous
reports [6,7,14–16]. This is important in view of the comparison of
our results with known international results on outcome of
neonatal sepsis cases. During the study period antimycotic
prophylaxis was not prescribed to any infant.
The only difference between our study population and earlier
described groups seems to be the prevalence of ROP and of BPD.
Cumulative ROP incidences have been reported in 51% of
children after GNS and in 67–86% of children after NCS
[21,28,29]. In our study we found a cumulative ROP incidence of
30% in the NCS cohort and of 24% in the GNS cohort, which is
lower than previously reported. The high awareness for oxygen
radical damage and close ophthalmological monitoring and
follow-up in our cohort may have contributed to these low
incidences of ROP as continued inflammation and oxygen use are
risk factors for sepsis associated morbidities such as BPD and
ROP.
Also, the cumulative incidence of BPD in our population, 16%
in the GNS cohort and 24% in the NCS cohort, was low
compared to previously published reports [3], [30], [31]. This may
be explained by the fact that in our study infants below 25 weeks
GA with a high risk for pulmonary complications were not
present. At that time infants below a gestational age of 25 weeks
were not actively treated in the Netherlands.
As far as we know this is the first report comparing outcome
between neonates experiencing NCS or GNS with the outcome of
uncomplicated controls admitted at the same NICU and treated
with the same routine NICU care. This was made possible by
highly digitalized databases in which both the clinical course and
long- term outcome is registered for the entire NICU population of
infants born at a gestational age below 30 weeks. The loss to
follow- up in our population was limited as a result of
a standardized policy of long term follow- up.
This study has several limitations. Maternal education was not
recorded in the early years of the study period and lumbar
punctures were not routinely included in the protocol for sepsis
work-up until the latter half of the study period. So for both these
important factors that may be important for outcome (the
presence of meningitis and maternal education) insufficient data
were available. This may have influenced our results. Also it is
possible that infants with false negative culture results, but with
clinical sepsis, were not included in this data set as they were not
retrieved by our search from the microbiology databases.
Since this study was performed retrospectively, neurodevelop-
mental clinicians and neuropsychologists of our outpatient clinic
were not blinded for the medical history and outcome evaluation
may have differed between sepsis cohort infants and control
infants. This information bias may have lead to overestimation of
the effect of sepsis.
Another limitation of the study might be that it contains
a relatively small number of sepsis cases, especially in the NCS
cohort. The comparison of the distribution of clinical character-
istics between the NCS cohort and the GNS cohort and the
analysis of the long-term outcome demonstrated no statistically
significant differences. However, due to the small number of cases
a type II error cannot be excluded. From a clinical perspective, the
increased ORs for adverse outcome due to a clinical sepsis with
inflammatory damage by itself are probably much more important
than the specific causative organism as is demonstrated viewing
the ORs for adverse outcome comparing both GNS and NCS
groups with uncomplicated controls. Clinical experience supports
these outcome data. However, larger prospective multicentre
studies are needed to construct possible prediction models for
neonatal sepsis and its outcome.
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